16,957 Shares in Electromed, Inc. $ELMD Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Electromed, Inc. (NYSE:ELMD) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 16,957 shares of the company’s stock, valued at approximately $416,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.20% of Electromed as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey acquired a new position in Electromed in the 2nd quarter worth $32,000. Financial Consulate Inc. purchased a new stake in shares of Electromed during the third quarter worth about $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Electromed in the second quarter worth about $83,000. New York State Common Retirement Fund purchased a new position in Electromed in the second quarter valued at about $103,000. Finally, Spire Wealth Management grew its stake in Electromed by 22.7% during the 2nd quarter. Spire Wealth Management now owns 5,405 shares of the company’s stock valued at $119,000 after purchasing an additional 1,000 shares in the last quarter. 40.82% of the stock is currently owned by hedge funds and other institutional investors.

Electromed Stock Performance

Electromed stock opened at $30.06 on Tuesday. Electromed, Inc. has a 1 year low of $17.73 and a 1 year high of $35.40. The firm’s 50-day moving average is $28.44 and its 200-day moving average is $24.88. The company has a market cap of $250.71 million, a P/E ratio of 40.08 and a beta of 0.27.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ELMD. Zacks Research lowered Electromed from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 29th. Roth Mkm reissued a “buy” rating and issued a $36.00 target price (up previously from $35.00) on shares of Electromed in a research report on Thursday, November 13th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $36.50.

Electromed Profile

Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.